Y-mAbs Announces Regulatory Filing for DANYELZA in Brazil
NEW YORK - Y-mAbs Therapeutics, Inc. , a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of... | September 27, 2022